J
Jukka Sairanen
Researcher at University of Helsinki
Publications - 25
Citations - 1278
Jukka Sairanen is an academic researcher from University of Helsinki. The author has contributed to research in topics: Interstitial cystitis & Medicine. The author has an hindex of 11, co-authored 18 publications receiving 1121 citations. Previous affiliations of Jukka Sairanen include Helsinki University Central Hospital.
Papers
More filters
Journal ArticleDOI
Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal
Joop P. van de Merwe,Jørgen Nordling,Pierre Bouchelouche,Kirsten Bouchelouche,Mauro Cervigni,L. Kurosch Daha,Suzy Elneil,Magnus Fall,Gero Hohlbrugger,Paul P. Irwin,S. A. Mortensen,Arndt van Ophoven,John L. Osborne,Ralph Peeker,Benedikte Richter,Claus R. Riedl,Jukka Sairanen,Martina Tinzl,Jean-Jacques Wyndaele +18 more
TL;DR: The name IC has become misleading and is replaced by BPS, in line with recent nomenclature recommendations by the European Association of Urology and based on the axial structure of the International Association for the Study of Pain classification.
Journal ArticleDOI
Primary evaluation of patients suspected of having interstitial cystitis (IC).
Jørgen Nordling,F.H Anjum,J.J Bade,Kirsten Bouchelouche,Pierre Bouchelouche,Mauro Cervigni,Sohier Elneil,Magnus Fall,Tage Hald,Tomáš Hanuš,H Hedlund,Gero Hohlbrugger,Thomas Horn,Svend Larsen,M Leppilahti,S. A. Mortensen,M Nagendra,P.D Oliveira,John L. Osborne,Claus R. Riedl,Jukka Sairanen,Martina Tinzl,Jean-Jacques Wyndaele +22 more
Journal ArticleDOI
Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine a
TL;DR: In this article, the authors evaluated patients with interstitial cystitis who had been on cyclosporine A treatment for at least a year and found that cyclospora A treatment was safe and effective in treating interstitial Cystitis.
Journal ArticleDOI
Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report
Magnus Fall,Jørgen Nordling,Mauro Cervigni,Paulo Dinis Oliveira,Jennifer Yonaitis Fariello,Philip M. Hanno,Christina Kåbjörn-Gustafsson,Yr Logadottir,Jane Meijlink,Nagendra Mishra,Robert M. Moldwin,Loredana Nasta,Jörgen Quaghebeur,Vicki Ratner,Jukka Sairanen,Rajesh Taneja,Hikaru Tomoe,Tomohiro Ueda,Gjertrud Wennevik,Kristene Whitmore,Jean-Jacques Wyndaele,Andrew Zaitcev +21 more
TL;DR: BPS is a symptom syndrome without specific objective findings and should be used for other patients fulfilling the ESSIC definitions and the term IC should preferably be reserved for HLD patients.
Journal ArticleDOI
Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it
Jukka Sairanen,Mikael Leppilahti,Teuvo L.J. Tammela,Ilkka Paananen,Sirpa Aaltomaa,Kimmo Taari,Mirja Ruutu +6 more
TL;DR: The HRQoL questionnaire can be used in evaluating QoL in PBS/IC patients and reflected well the post-treatment GRA, according to the changes in global response assessment (GRA).